Aequus Pharmaceuticals AQSZF Stock
Aequus Pharmaceuticals Price Chart
Aequus Pharmaceuticals AQSZF Financial and Trading Overview
| Aequus Pharmaceuticals stock price | 0.0026 USD |
| Previous Close | 0.0011 USD |
| Open | 0.0011 USD |
| Bid | 0.0011 USD x 3989500 |
| Ask | 0.0027 USD x 2200000 |
| Day's Range | 0.0011 - 0.0011 USD |
| 52 Week Range | 0.0001 - 0.008 USD |
| Volume | 8.03K USD |
| Avg. Volume | 246.66K USD |
| Market Cap | 145.9K USD |
| Beta (5Y Monthly) | -0.265 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AQSZF Valuation Measures
| Enterprise Value | 6.16M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.15884821 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 6.708 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Aequus Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -0.265 |
| 52-Week Change | -72.50% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.008 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.001732 USD |
| 200-Day Moving Average | 0.00234835 USD |
AQSZF Share Statistics
| Avg. Volume (3 month) | 246.66K USD |
| Avg. Daily Volume (10-Days) | 188.37K USD |
| Shares Outstanding | 132.63M |
| Float | 113.16M |
| Short Ratio | N/A |
| % Held by Insiders | 14.68% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | -71.45% |
| Operating Margin (ttm) | -34.82% |
| Gross Margin | 56.94% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -68.066% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 918.47K USD |
| Revenue Per Share (ttm) | 0.007 USD |
| Quarterly Revenue Growth (yoy) | 69.69% |
| Gross Profit (ttm) | 523.04K USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -656339 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.86K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 6.03M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.028 |
| Book Value Per Share (mrq) | -0.037664797 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -115840 USD |
| Levered Free Cash Flow (ttm) | 241.19K USD |
Profile of Aequus Pharmaceuticals
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 200 Granville Street |
| ZIP | V6C 1S4 |
| Phone | 604 336 7906 |
| Website | https://www.aequuspharma.ca |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Q&A For Aequus Pharmaceuticals Stock
What is a current AQSZF stock price?
Aequus Pharmaceuticals AQSZF stock price today per share is 0.0026 USD.
How to purchase Aequus Pharmaceuticals stock?
You can buy AQSZF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aequus Pharmaceuticals?
The stock symbol or ticker of Aequus Pharmaceuticals is AQSZF.
Which industry does the Aequus Pharmaceuticals company belong to?
The Aequus Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.
How many shares does Aequus Pharmaceuticals have in circulation?
The max supply of Aequus Pharmaceuticals shares is 132.63M.
What is Aequus Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Aequus Pharmaceuticals PE Ratio is now.
What was Aequus Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Aequus Pharmaceuticals EPS is -0.01 USD over the trailing 12 months.
Which sector does the Aequus Pharmaceuticals company belong to?
The Aequus Pharmaceuticals sector is Healthcare.